Overview

LAssa Fever Adjunct Treatment With DEXamethasone

Status:
RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
Dexamethasone is a corticosteroid which can modulate inflammatory-mediated tissue damage associated with a wide range of infectious diseases. Dexamethasone is routinely used for treatment of tuberculous meningitis and for pneumococcal meningitis in adults. In Coronavirus Disease 2019 (COVID-19) dexamethasone is also effectively preventing immune mediated damage of the lungs. There is also indication that dexamethasone may be promising in severe LF.
Phase:
PHASE2
Details
Lead Sponsor:
Bernhard Nocht Institute for Tropical Medicine
Treatments:
Dexamethasone
Ribavirin